NR4A1 and acute myeloid leukemia: Modulation of NR4A receptor activity can influence disease outcome, as demonstrated in acute myeloid leukemia (AML), with the identification of specific drugs that modulate NR4A1/3 expression and NR4A-gene signatures in AML cells (105, 106).